Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Astrocyte Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Astrocyte Pharmaceuticals

Astrocyte Pharmaceuticals

Astrocyte Pharmaceuticals: Innovating neuroprotective strategies through small molecule medicines.

HQ
Groton, CT, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Astrocyte Pharmaceuticals was founded with the core mission of developing innovative neuroprotective strategies to protect and repair neurons by selectively stimulating astrocytes. The company focuses on creating small molecule pharmaceutical medicines aimed at providing neuroprotection for a range of brain injuries, including traumatic brain injuries (TBI), concussions, strokes, and neurodegenerative diseases. Their market focus is on advancing these treatments to improve outcomes for patients suffering from these debilitating conditions.

Notable affiliated individuals include experts in neuroscience and pharmaceutical development, though specific names are not provided. Key achievements include the successful advancement of their neuroprotective small molecule medicines through various stages of research and development. The overall impact of Astrocyte Pharmaceuticals lies in their potential to significantly improve the quality of life for patients with brain injuries and neurodegenerative diseases by reducing damage and promoting healing through innovative treatments.

Astrocyte Pharmaceuticals - Similar Companies

NeurAegis logo

NeurAegis

neuraegis.com

NeuroPro Therapeutics logo

NeuroPro Therapeutics

Alcyone Lifesciences logo

Alcyone Lifesciences

Astria Biosciences logo

Astria Biosciences

NeuroCytonix logo

NeuroCytonix

neurocytonix.com

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

NeuExcell Therapeutics logo

NeuExcell Therapeutics

neuexcell.com

Zocere logo

Zocere

zocere.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Axial Therapeutics logo

Axial Therapeutics

Neuraly logo

Neuraly

neuralymed.com

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Aptinyx logo

Aptinyx

aptinyx.com

NeuCyte logo

NeuCyte

neucyte.com

Astrocyte Pharmaceuticals - Quick Facts

Who are Astrocyte Pharmaceuticals' competitors?

Companies similar to Astrocyte Pharmaceuticals include NeurAegis, NeuroPro Therapeutics, Alcyone Lifesciences and Astria Biosciences.

When was Astrocyte Pharmaceuticals founded?

Astrocyte Pharmaceuticals was founded in 2014.

Where is Astrocyte Pharmaceuticals' headquarters located?

Astrocyte Pharmaceuticals' headquarters is located in Groton, CT, US.

When was Astrocyte Pharmaceuticals' last funding round?

Astrocyte Pharmaceuticals' most recent funding round was for $6M (USD) in August 2023.

How much has Astrocyte Pharmaceuticals raised to-date?

As of Aug 18, 2023, Astrocyte Pharmaceuticals has raised a total of $31.9M (USD).

How many employees does Astrocyte Pharmaceuticals have?

Astrocyte Pharmaceuticals has 30 employees as of Feb 5, 2024.

Astrocyte Pharmaceuticals - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified